Skip to content
amineptine

Structure via PubChem · Public domain (PubChem)

EntityQ44822059· pop 19· linked from 1,314 articles

amineptine

Sign in to save

Also known as Survector

Amineptine, formerly sold under the brand name Survector among others, is an atypical antidepressant of the tricyclic antidepressant (TCA) family. It acts as a selective and mixed dopamine reuptake inhibitor and releasing agent, and to a lesser extent as a norepinephrine reuptake inhibitor.

Chemical data

Formula
C22H27NO2
Molecular weight
337.5 g/mol
IUPAC name
7-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylamino)heptanoic acid
SMILES
C1CC2=CC=CC=C2C(C3=CC=CC=C31)NCCCCCCC(=O)O
InChIKey
ONNOFKFOZAJDHT-UHFFFAOYSA-N
XLogP
2.1
Polar surface area
49.3 Ų
H-bond donors
2
H-bond acceptors
3
Formal charge
0

via PubChem

Drug data · ChEMBL

Withdrawn
Max clinical phase
Approved
Molecule type
Small molecule
Indications
major depressive disorder

via ChEMBL · EBI

Research

287 papers

via PubMed

Wikidata facts

Subclass of
carboxylic acid
Mass
337.204179104
Has use
medication
Show 5 more facts
canonical SMILES
OC(=O)CCCCCCNC1c2ccccc2CCc2ccccc12
NCI Thesaurus ID
C74142
subject has role
tricyclic antidepressant
Commons category
Amineptine
chemical formula
C₂₂H₂₇NO₂
Sources (2)

via Wikidata · CC0

~9 min read

Encyclopedic overview

22 sections
Contents
  • Medical uses
  • Contraindications
  • Precautions for use
  • Effects on the fetus
  • Side effects
  • Dermatological
  • Psychiatric
  • Abuse and dependence
  • Withdrawal
  • Cardiovascular
  • Hepatic
  • Gastrointestinal
  • Immunological
  • Pharmacology
  • Pharmacodynamics
  • Pharmacokinetics
  • Society and culture
  • Brand names
  • Legal status
  • Research
  • Wakefulness
  • References

Amineptine, formerly sold under the brand name Survector among others, is an atypical antidepressant of the tricyclic antidepressant (TCA) family. It acts as a selective and mixed dopamine reuptake inhibitor and releasing agent, and to a lesser extent as a norepinephrine reuptake inhibitor.

Amineptine was developed by the French Society of Medical research in the 1960s. Introduced in France in 1978 by the pharmaceutical company Servier, amineptine soon gained a reputation for abuse due to its short-lived, but pleasant, stimulant effect experienced by some patients.

Excerpted from Wikipedia’s “amineptine” article, available under the CC BY-SA 4.0 licence.